Prevalence and Predictive Clinical Characteristics of Metabolically Healthy Obesity in Obese Children and Adolescents

• Published in: Curēus (Palo Alto, CA) Vol. 15; no. 3; p. e35935
• Main Authors: Dundar, Ismail, Akinci, Aysehan
• Format: Journal Article
• Language: English
• Published: United States Cureus Inc 09-03-2023; Cureus
• Subjects: Abdomen; Blood pressure; Body fat; Body mass index; Comorbidity; Endocrinology/Diabetes/Metabolism; Environmental Health; Gender; Gestational age; Gestational diabetes; Glucose; Health care; High density lipoprotein; Homeostasis; Hypothyroidism; Immunoassay; Insulin resistance; Laboratories; Life expectancy; Lipoproteins; Liver diseases; Medical records; Metabolic syndrome; Metabolism; Obesity; Pediatrics; Puberty; Statistical analysis; Teenagers; United States > US; Indianapolis Indiana; Chicago Illinois; metabolic syndrome; metabolically healthy obesity; metabolically unhealthy obesity; obesity; childhood obesity
• ISSN: 2168-8184; 2168-8184
• DOI: 10.7759/cureus.35935

The increasing prevalence of childhood obesity and accompanying comorbidities all over the world constitutes one of the most important public health problems of the changing world. The frequency and causes of the metabolically healthy obesity (MHO) phenotype in children is not clear.
The objective is to determine the prevalence of the MHO phenotype in obese Turkish children and adolescents and to identify clinical and biochemical indicators for this phenotype.
Eight hundred forty-seven obese children and adolescents, aged 3-18 years with BMI-SDS >+2 SD from the obesity outpatient clinic were included. Demographic, anthropometric, and physical examination information was collected from patient medical files. In addition, obesity-related comorbidities and results of laboratory tests were obtained. For study purposes, obese patients with no cardiometabolic risk factors were accepted as MHO, and those with ≥1 cardiometabolic risk factor were considered metabolically unhealthy obese (MUO). MHO was defined according to Damanhoury's criteria.
Out of 847 children (mean age 10.6±3.4 years) who met the study criteria, 289 (34.1%) were diagnosed with MHO. Being younger, prepubertal, having relatively low BMI, low waist/hip ratio, low insulin resistance (HOMA-IR) index, high high-density lipoprotein, low triglyceride, low fasting insulin and glucose levels, low uric acid and low alanine transaminase (ALT) levels were associated with MHO.
The MHO phenotype was present in just over a third of this obese pediatric cohort. The most important factors associated with MHO; age, waist-hip ratio, and BMI were determined.